Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study
Drugs in R&D · 2026-06 · 26 (2) · 187-196
DOI: 10.1007/s40268-026-00547-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drugs in R&D, online erschienen am 01.07.2026. Verfasst von Sudershan Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Pharmacokinetics, Sun Pharmaceutical Industries Limited, Gurgaon, India. Hauptthemen laut MEDLINE: Amines, gamma-Aminobutyric Acid, Cyclohexanecarboxylic Acids, Analgesics. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sun Pharmaceutical Industries Limited, Mumbai, India..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology and Pharmacokinetics, Sun Pharmaceutical Industries Limited, Gurgaon, India.
- Clinical Pharmacology Unit, Sun Pharmaceutical Industries Limited, Gurgaon, India.
- Formulation Department, Sun Pharma Advanced Research Company (SPARC) Ltd, Mumbai, India.
- Medical Affairs and Clinical Research, Sun Pharma Laboratories Limited, Mumbai, India.
- Medical Affairs and Clinical Research, Sun Pharmaceutical Industries Limited, Mumbai, India. PrashantH.Devkare@sunpharma.com.
Förderung
- Sun Pharmaceutical Industries Limited, Mumbai, India.
Zitieren
APA
Kumar, S., Khuroo, A., Gurule, S. J., Mehra, S., Tiwari, H. K., Zala, Y., Kamala, V. R. R., Kandukuri, M., Dharmadhikari, S., Devkare, P., & Khandhedia, C. (2026). Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study. Drugs in R&D, 26(2), 187-196. https://doi.org/10.1007/s40268-026-00547-8
Vancouver
Kumar S, Khuroo A, Gurule SJ, Mehra S, Tiwari HK, Zala Y, et al. Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study. Drugs in R&D. 2026;26(2):187-196. doi:10.1007/s40268-026-00547-8
BibTeX
@article{Kumar2026,
author = {Kumar, Sudershan and Khuroo, Arshad and Gurule, Sanjay Jagannath and Mehra, Sachin and Tiwari, Hari Krishan and Zala, Y and Kamala, Venkata Rama Rao and Kandukuri, Madhu and Dharmadhikari, Shruti and Devkare, Prashant and Khandhedia, Chintan},
title = {Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study},
journal = {Drugs in R&D},
year = {2026},
volume = {26},
number = {2},
pages = {187--196},
doi = {10.1007/s40268-026-00547-8}
}
EUVIMED